{"SPADE_N_06335": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06335", "Peptide Name": "Peptide L12D", "Source": "Acetylation", "Family": "", "Gene": "Not found", "Sequence": "KWKSFLKTFKSLKKTVLHTLLKAISS", "Sequence Length": 26, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:HeLa (IC50=2.63±0.07 µmol/L)", "Hemolytic Activity": "Human red blood cells:MHC=20.81±0.03 μmol/L", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Acetylation", "C-terminal Modification": "Amidation", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C139H229N35O32", "Mass": 3033.69, "PI": 10.78, "Net Charge": 8, "Hydrophobicity": -0.06, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Role of helicity on the anticancer mechanism of action of cationic-helical peptides", "Pubmed ID": "22837667", "Reference": "Int J Mol Sci. 2012;13(6)6849-6862.", "Author": "Huang YB, He LY, Jiang HY, Chen YX.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22837667"}], "Frequent Amino Acids": "KLS", "Absent Amino Acids": "CDEGMNOPQRUY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 17, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06336", "Similarity": 1.0, "Sequence": "KWKSFLKTFKSLKKTVLHTLLKAISS"}, {"SPADE_ID": "SPADE_N_06337", "Similarity": 1.0, "Sequence": "KWKSFLKTFKSLKKTVLHTLLKAISS"}, {"SPADE_ID": "SPADE_UN_11417", "Similarity": 1.0, "Sequence": "KWKSFLKTFKSLKKTVLHTLLKAISS"}]}}}